A detailed history of Acadian Asset Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 315,744 shares of PFE stock, worth $8.79 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
315,744
Previous 496,092 36.35%
Holding current value
$8.79 Million
Previous $14.3 Million 38.67%
% of portfolio
0.03%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$25.89 - $29.73 $4.67 Million - $5.36 Million
-180,348 Reduced 36.35%
315,744 $8.76 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $4.92 Million - $6.39 Million
-188,193 Reduced 27.5%
496,092 $14.3 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $3.92 Million - $4.58 Million
-122,229 Reduced 15.16%
684,285 $22.7 Million
Q2 2023

Aug 07, 2023

SELL
$36.12 - $41.79 $1.5 Million - $1.74 Million
-41,644 Reduced 4.91%
806,514 $29.6 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $885,881 - $1.15 Million
22,490 Added 2.72%
848,158 $34.6 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $6.77 Million - $8.84 Million
162,209 Added 24.45%
825,668 $42.3 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $15.8 Million - $19.3 Million
361,686 Added 119.85%
663,459 $29 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $15.8 Million - $19.3 Million
361,686 Added 119.85%
663,459 $29 Million
Q2 2022

Aug 09, 2022

SELL
$46.53 - $55.17 $7.19 Million - $8.53 Million
-154,586 Reduced 33.87%
301,773 $15.8 Million
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $127 Million - $157 Million
-2,768,897 Reduced 85.85%
456,359 $23.6 Million
Q4 2021

Feb 10, 2022

SELL
$41.32 - $61.25 $36.1 Million - $53.5 Million
-872,665 Reduced 21.3%
3,225,256 $190 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $62.4 Million - $80.1 Million
-1,589,603 Reduced 27.95%
4,097,921 $176 Million
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $105 Million - $119 Million
2,933,999 Added 106.55%
5,687,524 $223 Million
Q1 2021

May 11, 2021

SELL
$33.49 - $37.77 $21.4 Million - $24.2 Million
-640,405 Reduced 18.87%
2,753,525 $99.8 Million
Q4 2020

Feb 11, 2021

SELL
$33.47 - $42.56 $23.9 Million - $30.4 Million
-714,812 Reduced 17.4%
3,393,930 $125 Million
Q3 2020

Nov 09, 2020

BUY
$31.75 - $37.25 $16.4 Million - $19.2 Million
515,826 Added 14.36%
4,108,742 $151 Million
Q2 2020

Aug 12, 2020

BUY
$30.12 - $36.54 $65.2 Million - $79.1 Million
2,163,632 Added 151.38%
3,592,916 $117 Million
Q1 2020

May 11, 2020

BUY
$27.03 - $38.62 $34.1 Million - $48.7 Million
1,261,443 Added 751.57%
1,429,284 $46.7 Million
Q4 2019

Feb 06, 2020

SELL
$32.92 - $37.36 $19.6 Million - $22.3 Million
-596,354 Reduced 78.04%
167,841 $6.58 Million
Q3 2019

Nov 07, 2019

SELL
$32.49 - $42.13 $20.7 Million - $26.8 Million
-636,944 Reduced 45.46%
764,195 $27.5 Million
Q2 2019

Aug 08, 2019

SELL
$36.98 - $41.52 $83.6 Million - $93.8 Million
-2,259,408 Reduced 61.72%
1,401,139 $60.7 Million
Q1 2019

May 09, 2019

SELL
$37.5 - $41.2 $12.5 Million - $13.7 Million
-333,169 Reduced 8.34%
3,660,547 $155 Million
Q4 2018

Feb 07, 2019

BUY
$38.47 - $43.86 $1.71 Million - $1.95 Million
44,364 Added 1.12%
3,993,716 $174 Million
Q3 2018

Oct 30, 2018

BUY
$34.47 - $41.81 $14.5 Million - $17.6 Million
422,018 Added 11.96%
3,949,352 $174 Million
Q2 2018

Jul 24, 2018

SELL
$32.98 - $35.16 $65,234 - $69,546
-1,978 Reduced 0.06%
3,527,334 $128 Million
Q1 2018

Apr 12, 2018

BUY
$31.91 - $37.02 $8.63 Million - $10 Million
270,358 Added 8.3%
3,529,312 $125 Million
Q4 2017

Jan 18, 2018

SELL
$33.26 - $35.29 $1.34 Million - $1.42 Million
-40,148 Reduced 1.22%
3,258,954 $118 Million
Q3 2017

Oct 13, 2017

BUY
$31.0 - $34.15 $102 Million - $113 Million
3,299,102
3,299,102 $118 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $156B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.